Postmarketing surveillance of sumatriptan : patient population, efficacy, and adverse effects
A postmarketing surveillance survey of sumatriptan use comprised 32 questions including patient demographics, headache history, and sumatriptan experience. One hundred and forty-one questionnaires were sent out, and 109 patients responded; a total of 108 patients were included in the data analysis....
Main Author: | Wang, Yu-Chin Lily |
---|---|
Format: | Others |
Published: |
Scholarly Commons
1994
|
Subjects: | |
Online Access: | https://scholarlycommons.pacific.edu/uop_etds/2273 https://scholarlycommons.pacific.edu/cgi/viewcontent.cgi?article=3272&context=uop_etds |
Similar Items
-
Pre-treatment with sumatriptan for cilostazol induced headache in healthy volunteers
by: Katrine Falkenberg, et al.
Published: (2018-08-01) -
Efficacy and safety of erenumab in women with a history of menstrual migraine
by: Jelena M. Pavlovic, et al.
Published: (2020-08-01) -
Cilostazol induced migraine does not respond to sumatriptan in a double blind trial
by: Katrine Falkenberg, et al.
Published: (2018-02-01) -
Treatment patterns in patients using triptan and prophylactic medication: an analysis of clinical practice prior to the introduction of CGRP antagonists
by: Huber CA, et al.
Published: (2019-07-01) -
The Use of Osteoporotic Medications Following a Fracture
by: Herman, Elizabeth O'Brien
Published: (2006)